Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03384914
Recruitment Status : Recruiting
First Posted : December 28, 2017
Last Update Posted : September 17, 2019
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2022
Estimated Study Completion Date : March 2023